Top Markets
#1 MowCat MowCat +48.89%
#2 Bermuda Shorts Bermuda Shorts +30.33%
#3 Velvet Velvet +26.11%
#4 aPriori aPriori +22.89%
#5 Derive Derive +19.95%
#6 Biconomy Biconomy +19.15%
#7 Audiera Audiera +18.63%
#8 Quack AI Quack AI +16.83%
#9 Perle Perle +13.71%
#10 Block Street Block Street +10.44%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.

AzurRx BioPharma, Inc.

AZRX
Rangering i aksjer #35193
AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12... AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by resistant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).
Aksjekurs
$3.45
Sist synkronisert: 2021-09-21
Markedsverdi
$4.29M
Endring (1 dag)
2.07%
Endring (1 år)
0.00%
Land
US
Handel AzurRx BioPharma, Inc. (AZRX)

Kategori

Healthcare
Aksjeprishistorikk for AzurRx BioPharma, Inc. (AZRX)
Høyeste sluttskurs: $5.04 den 2021-09-01

Laveste sluttskurs: $50.52 den 2016-10-01
Aksjeprishistorikk for AzurRx BioPharma, Inc. fra 2016 til 2026
Årlig aksjeprisytelse
År Ytelse
2021 -37.15%
2020 -9.98%
2019 -42.81%
2018 -49.10%
2017 -28.62%
2016 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE